Early and persistent expression of phosphorylated α-synuclein in the enteric nervous system of A53T mutant human α-synuclein transgenic mice

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 12, 2014, Pages 1144-1151

  Bencsik, Anna ^a   Muselli, Letizia ^a   Leboidre, Mikael ^a   Lakhdar, Latifa ^b   Baron, Thierry ^a  

^a FRENCH AGENCY FOR FOOD   (France)

^b PFEA   (France)

Author keywords

A53T; Enteric nervous system; Lewy body dementia; Paraffin embedded tissue blot; Parkinson disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; PARAFFIN; PROTEINASE K; SERINE;

AGE; ALPHA SYNUCLEIN GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BIOACCUMULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MODEL; GENE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE INNERVATION; MOUSE; MOUSE MODEL; MYENTERIC PLEXUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SYNUCLEINOPATHY; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; PARKINSON DISEASE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; ENTERIC NERVOUS SYSTEM; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PARKINSON DISEASE; PHOSPHORYLATION;

EID: 84915763819     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000137     Document Type: Article

References (51)

1. Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004; 364:1167-69
2. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Gen 1998;18:106-8
3. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47
4. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003;302:841
5. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-73
6. Anderson JP, Walker DE, Goldstein JM, et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 2006;281:29739-52
7. Hashimoto M, Hsu LJ, Xia Y, et al. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 1999;10:717-21
8. Negro A, Brunati AM, Donella-Deana A, et al. Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J 2002;16:210-12
9. Okochi M, Walter J, Koyama A, et al. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem 2000; 275:390-97
10. Uversky VN, Yamin G, Souillac PO, et al. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett 2002;517: 239-44
11. Beach TG, Adler CH, Dugger BN, et al. Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol 2013;72: 130-36
12. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010;119:689-702
13. Mu L, Sobotka S, Chen J, et al. Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 2013;72:119-29
14. Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov Disord 2013;28:237-40
15. Hilton D, Stephens M, Kirk L, et al. Accumulation of alpha-synuclein in the bowel of patients in the preclinical phase of Parkinson's disease. Acta Neuropathol 2014;127:235-41
16. Cersosimo MG, Raina GB, Pecci C, et al. Gastrointestinal manifestations in Parkinson's disease: Prevalence and occurrence before motor symptoms. J Neurol 2013;260:1332-38
17. Lebouvier T, Chaumette T, Damier P, et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 2008;57:1741-43
18. Kuo YM, Li Z, Jiao Y, et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Gen 2010;19:1633-50
19. Zhu HC, Zhao J, Luo CY, et al. Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus. J Mol Neurosci 2012;47:15-25
20. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211
21. Giasson BI, Duda JE, Quinn SM, et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 2002;34:521-33
22. Waxman EA, Giasson BI. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol 2008;67: 402-16
23. Mougenot AL, Bencsik A, Nicot S, et al. Transmission of prion strains in a transgenic mouse models overexpressing human A53T mutated alpha-synuclein. J Neuropathol Exp Neurol 2011;70:377-85
24. Specht CG, Schoepfer R. Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci 2001;2:11
25. Moolenbeek C, Ruitenberg EJ. The ''Swiss roll'': A simple technique for histological studies of the rodent intestine. Lab Anim 1981;15:57-59
26. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, et al. The paraffinembedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000;156:51-56
27. Lezmi S, Bencsik A, Baron T. PET-blot analysis contributes to BSE strain recognition in C57Bl/6 mice. J Histochem Cytochem 2006;54: 1087-94
28. Bencsik A, Leboidre M, Debeer S, et al. Unique properties of the classical bovine spongiform encephalopathy strain and its emergence from H-type bovine spongiform encephalopathy substantiated by VM transmission studies. J Neuropathol Exp Neurol 2013;72:211-18
29. Ritchie DL, Head MW, Ironside JW. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 2004;30:360-68
30. Schulz-Schaeffer WJ, Fatzer R, Vandevelde M, et al. Detection of PrP (Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol Suppl 2000;(16):173-80
31. Lezmi S, Baron TG, Bencsik AA. Is the presence of abnormal prion protein in the renal glomeruli of feline species presenting with FSE authentic? BMC Vet Res 2010;6:41
32. Schulz-Schaeffer WJ. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol 2010;120:131-43
33. Braak H, de Vos RA, Bohl J, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006; 396:67-72
34. Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PloS One 2010;5:e12728
35. Shannon KM, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 2012;27:709-15
36. Wakabayashi K, Mori F, Tanji K, et al. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 2010;120:1-12
37. Auluck PK, Caraveo G, Lindquist S. Alpha-synuclein: Membrane interactions and toxicity in Parkinson's disease. Ann Rev Cell Dev Biol 2010;26:211-33
38. Wan OW, Chung KK. The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease. PloS One 2012;7:e38545
39. Goetze O, Nikodem AB, Wiezcorek J, et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 2006;18:369-75
40. Hardoff R, Sula M, Tamir A, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001;16: 1041-47
41. Awad RA. Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease. World J Gastroenterol 2011;17:5035-48
42. Noorian AR, Rha J, Annerino DM, et al. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system. Neurobiol Dis 2012;48:9-19
43. Wang L, Fleming SM, Chesselet MF, et al. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport 2008;19:873-76
44. Wang L, Magen I, Yuan PQ, et al. Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterol Motil 2012;24:e425-36
45. Lemaire-Vieille C, Schulze T, Podevin-Dimster V, et al. Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice. Proc Natl Acad Sci USA 2000;97:5422-27
46. Annerino DM, Arshad S, Taylor GM, et al. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 2012;124:665-80
47. Betemps D, Verchere J, Brot S, et al. Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological alpha-synuclein by enhanced ELISA. Acta Neuropathol Commun 2014;2:29
48. Gispert S, Del Turco D, Garrett L, et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 2003;24:419-29
49. Farrell KF, Krishnamachari S, Villanueva E, et al. Non-motor parkinsonian pathology in aging A53T alpha-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function. J Neurochem 2014;128:536-46
50. Braak H, Rub U, Gai WP, et al. Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-36
51. Lema Tome CM, Tyson T, Rey NL, et al. Inflammation and alphasynuclein's prion-like behavior in Parkinson's diseaseVIs there a link? Mol Neurobiol 2013;47:561-74